This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:Peganum harmala alkaloids: Difference between revisions
Jump to navigation
Jump to search
>David Hedlund Creating Template:Peganum harmala alkaloids |
>David Hedlund Creating Template:Peganum harmala alkaloids |
(No difference)
| |
Revision as of 02:02, 16 July 2021
| Alkaloid | Content | Type |
|---|---|---|
| Desoxypeganine[1] | MAO-A[2] | |
| Harmalicidine[3] | ||
| Harmaline (harmidine) | 0.25%[4]–0.79%[5]–5.6%[6] | Reversible inhibitor of monoamine oxidase A (RIMA) |
| Harmalol | 0.6%[6]–3.90%[4] | |
| Harmane (harman) | 0.16%[4] | MAO-A and MAO B[7] |
| Harmine (banisterine, telepathine) | 0.44%[5]–1.84%[4]–4.3%[6] – The coatings of the seeds are said to contain large amounts of harmine.[8] | Reversible inhibitor of monoamine oxidase A (RIMA) |
| Tetrahydroharmine (THH) | 0.1%[6] | Serotonine reuptake inhibitor[9] |
| Vasicine (peganine)[10] | 0.25%[5] | |
| Vasicinone[10] | 0.0007%[5] |
- ↑ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841998/
- ↑ Algorta, J; Pena, MA; Maraschiello, C; Alvarez-González, A; Maruhn, D; Windisch, M; Mucke, HA (March 2008). "Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral doses". Methods and findings in experimental and clinical pharmacology. 30 (2): 141–7. doi:10.1358/mf.2008.30.2.1159649. PMID 18560630.
- ↑ Lamchouri, F; Zemzami, M; Jossang, A; Abdellatif, A; Israili, ZH; Lyoussi, B (July 2013). "Cytotoxicity of alkaloids isolated from Peganum harmala seeds". Pakistan journal of pharmaceutical sciences. 26 (4): 699–706. PMID 23811445.
- ↑ 4.0 4.1 4.2 4.3 Hemmateenejad B, Abbaspour A, Maghami H, Miri R, Panjehshahin MR (August 2006). "Partial least squares-based multivariate spectral calibration method for simultaneous determination of beta-carboline derivatives in Peganum harmala seed extracts". Anal. Chim. Acta. 575 (2): 290–9. doi:10.1016/j.aca.2006.05.093. PMID 17723604.
- ↑ 5.0 5.1 5.2 5.3 Pulpati H, Biradar YS, Rajani M (2008). "High-performance thin-layer chromatography densitometric method for the quantification of harmine, harmaline, vasicine, and vasicinone in Peganum harmala". J AOAC Int. 91 (5): 1179–85. doi:10.1093/jaoac/91.5.1179
. PMID 18980138.
- ↑ 6.0 6.1 6.2 6.3 Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H (March 2010). "beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)". Food Chem. Toxicol. 48 (3): 839–45. doi:10.1016/j.fct.2009.12.019. PMID 20036304.
- ↑ Herraiz, T; Chaparro, C (18 January 2006). "Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee". Life sciences. 78 (8): 795–802. doi:10.1016/j.lfs.2005.05.074. PMID 16139309.
- ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedcdfa - ↑ Callaway, James C.; McKenna, Dennis; Grob, Charles S.; et al. (June 1999). "Pharmacokinetics of hoasca alkaloids in healthy humans". Journal of Ethnopharmacology. 65 (3): 243–56. doi:10.1016/S0378-8741(98)00168-8. ISSN 0279-1072. PMID 10404423.
- ↑ 10.0 10.1 Cite error: Invalid
<ref>tag; no text was provided for refs namednook